CSF1R and neoplasm: Furthermore, to specifically deplete macrophages and microglia, we treated AKT1-expressing larvae with the CSF-1R inhibitor Ki20227 that has previously been shown to deplete macrophages and to reduce tumor growth in a rodent melanoma model (Tham et al., 2015; Ohno et al., 2006).